The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy
A high selenium level is predictive of pCR in women treated for HER2-positive or triple-negative breast cancer. If confirmed, this observation may lead to a study investigating if selenium supplementation improves pCR rates and survival in breast cancer women receiving NAC.
Authors
- Róża Derkacz (ORCID: https://orcid.org/0000-0002-2904-5259)
- Karolina Osowiecka (ORCID: https://orcid.org/0000-0001-8931-9576)
- Jan Lubiński (ORCID: https://orcid.org/0000-0003-2931-3003)
- Tomasz Huzarski (ORCID: https://orcid.org/0000-0003-3857-4854)
- Wojciech Marciniak (ORCID: https://orcid.org/0000-0001-7270-0063)
- Marek Szwiec (ORCID: https://orcid.org/0000-0001-6981-6356)
- Joanna Tomiczek‐Szwiec (ORCID: https://orcid.org/0000-0001-8908-6610)
- Cezary Cybulski (ORCID: https://orcid.org/0000-0002-2819-3057)
- Steven A. Narod (ORCID: https://orcid.org/0000-0001-5798-0626)
- Jacek Gronwald (ORCID: https://orcid.org/0000-0002-3643-2871)
- Robert Sibilski
Institutions
- University of Opole (PL)
- University of Toronto (CA)
- Women's College Hospital (CA)
- Public Health Ontario (CA)
- International Hereditary Cancer Center (PL)
- Read-Gene (Poland) (PL)
- University of Zielona Góra (PL)
- University of Warmia and Mazury in Olsztyn (PL)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Cancers
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3390/cancers17050839
- Citations
- 2
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.76